Lakatta EG - Search Results

1

COL4A1 is associated with arterial stiffness by genome-wide association scan.

Tarasov KV, Sanna S, Scuteri A, Strait JB, Orrù M, Parsa A, Lin PI, Maschio A, Lai S, Piras MG, Masala M, Tanaka T, Post W, O'Connell JR, Schlessinger D, Cao A, Nagaraja R, Mitchell BD, Abecasis GR, Shuldiner AR, Uda M, Lakatta EG, Najjar SS. Tarasov KV, et al. Among authors: lakatta eg. Circ Cardiovasc Genet. 2009 Apr;2(2):151-8. doi: 10.1161/CIRCGENETICS.108.823245. Epub 2009 Feb 18. Circ Cardiovasc Genet. 2009. PMID: 20031579 Free PMC article.

2

Is the apoE4 allele an independent predictor of coronary events?

Scuteri A, Bos AJ, Zonderman AB, Brant LJ, Lakatta EG, Fleg JL. Scuteri A, et al. Among authors: lakatta eg. Am J Med. 2001 Jan;110(1):28-32. doi: 10.1016/s0002-9343(00)00639-2. Am J Med. 2001. PMID: 11152862

3

Effect of estrogen and progestin replacement on arterial stiffness indices in postmenopausal women.

Scuteri A, Lakatta EG, Bos AJ, Fleg JL. Scuteri A, et al. Among authors: lakatta eg. Aging (Milano). 2001 Apr;13(2):122-30. doi: 10.1007/BF03351534. Aging (Milano). 2001. PMID: 11405385

4

Improved arterial compliance by a novel advanced glycation end-product crosslink breaker.

Kass DA, Shapiro EP, Kawaguchi M, Capriotti AR, Scuteri A, deGroof RC, Lakatta EG. Kass DA, et al. Among authors: lakatta eg. Circulation. 2001 Sep 25;104(13):1464-70. doi: 10.1161/hc3801.097806. Circulation. 2001. PMID: 11571237 Clinical Trial.

5

Functional correlates of central arterial geometric phenotypes.

Scuteri A, Chen CH, Yin FC, Chih-Tai T, Spurgeon HA, Lakatta EG. Scuteri A, et al. Among authors: lakatta eg. Hypertension. 2001 Dec 1;38(6):1471-5. doi: 10.1161/hy1201.099291. Hypertension. 2001. PMID: 11751738

6

A quantitative and validated SAGE transcriptome reference for adult mouse heart.

Anisimov SV, Tarasov KV, Stern MD, Lakatta EG, Boheler KR. Anisimov SV, et al. Among authors: lakatta eg. Genomics. 2002 Aug;80(2):213-22. doi: 10.1006/geno.2002.6821. Genomics. 2002. PMID: 12160735

7

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease.

Lakatta EG, Levy D. Lakatta EG, et al. Circulation. 2003 Jan 7;107(1):139-46. doi: 10.1161/01.cir.0000048892.83521.58. Circulation. 2003. PMID: 12515756 Review. No abstract available.

8

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part II: the aging heart in health: links to heart disease.

Lakatta EG, Levy D. Lakatta EG, et al. Circulation. 2003 Jan 21;107(2):346-54. doi: 10.1161/01.cir.0000048893.62841.f7. Circulation. 2003. PMID: 12538439 Review. No abstract available.

9

Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging.

Lakatta EG. Lakatta EG. Circulation. 2003 Jan 28;107(3):490-7. doi: 10.1161/01.cir.0000048894.99865.02. Circulation. 2003. PMID: 12551876 Review. No abstract available.

10

Nitric oxide inhibition as a mechanism for blood pressure increase during salt loading in normotensive postmenopausal women.

Scuteri A, Stuehlinger MC, Cooke JP, Wright JG, Lakatta EG, Anderson DE, Fleg JL. Scuteri A, et al. Among authors: lakatta eg. J Hypertens. 2003 Jul;21(7):1339-46. doi: 10.1097/00004872-200307000-00023. J Hypertens. 2003. PMID: 12817182

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

723 results

Search Page